Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Perspective Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +7 vs. Q2 2025
- Shares held
- 43.7M
- +1.26M (+3.0%) vs. Q2 2025
- Total value
- $150.1M
- +$3.71M (+2.5%) vs. Q2 2025
- New holders
- 16
- 32 more added
- Sold out
- 9
- 30 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $297.6M |
| Q1 2026 | 138 | $333.1M |
| Q4 2025 | 117 | $105.0M |
| Q3 2025 | 105 | $150.1M |
| Q2 2025 | 98 | $146.3M |
| Q1 2025 | 112 | $96.4M |
| Q4 2024 | 135 | $150.7M |
| Q3 2024 | 127 | $654.9M |
| Q2 2024 | 105 | $384.9M |
| Q1 2024 | 104 | $294.6M |
| Q4 2023 | 52 | $14.7M |
| Q3 2023 | 49 | $9.99M |
| Q2 2023 | 50 | $22.0M |
| Q1 2023 | 42 | $17.8M |
| Q4 2022 | 48 | $4.26M |
| Q3 2022 | 35 | $3.70M |
| Q2 2022 | 43 | $5.19M |
| Q1 2022 | 39 | $5.79M |
| Q4 2021 | 45 | $6.78M |
| Q3 2021 | 43 | $9.99M |
| Q2 2021 | 48 | $13.9M |
| Q1 2021 | 57 | $20.2M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 2,760,861 | $9.47M | 0.00% | +1,137,473+70.1% | Added |
| Avidity Partners Management LP | 2,994,033 | $10.3M | 2.34% | +1,135,437+61.1% | Added |
| Vanguard Group Inc | 3,437,865 | $11.8M | 0.00% | +163,532+5.0% | Added |
| BlackRock, Inc. | 4,366,577 | $15.0M | 0.00% | +72,426+1.7% | Added |
| FMR LLC | 10,010,865 | $34.3M | 0.00% | −1,091,905−9.8% | Reduced |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −520,707−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −143,332−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −138,350−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −28,708−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −16,373−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,802−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | 0 | Sold out |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0 | $0 | 0.00% | −117−100.0% | Sold out |